Eagle Pharmaceuticals Inc (EGRX)
0.50
-0.05
(-9.09%)
USD |
OTCM |
Nov 04, 16:00
Eagle Pharmaceuticals Total Assets (Quarterly): 404.82M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 404.82M |
| March 31, 2023 | 414.18M |
| December 31, 2022 | 406.16M |
| September 30, 2022 | 386.45M |
| June 30, 2022 | 381.76M |
| March 31, 2022 | 320.16M |
| December 31, 2021 | 253.73M |
| September 30, 2021 | 256.26M |
| June 30, 2021 | 264.24M |
| March 31, 2021 | 259.97M |
| December 31, 2020 | 253.19M |
| September 30, 2020 | 248.16M |
| June 30, 2020 | 256.71M |
| March 31, 2020 | 361.94M |
| December 31, 2019 | 254.55M |
| September 30, 2019 | 257.04M |
| June 30, 2019 | 261.63M |
| March 31, 2019 | 259.45M |
| December 31, 2018 | 238.60M |
| September 30, 2018 | 268.79M |
| Date | Value |
|---|---|
| June 30, 2018 | 273.94M |
| March 31, 2018 | 249.30M |
| December 31, 2017 | 270.06M |
| September 30, 2017 | 266.89M |
| June 30, 2017 | 220.18M |
| March 31, 2017 | 224.82M |
| December 31, 2016 | 214.32M |
| September 30, 2016 | 146.72M |
| June 30, 2016 | 149.37M |
| March 31, 2016 | 128.70M |
| December 31, 2015 | 124.60M |
| September 30, 2015 | 122.22M |
| June 30, 2015 | 121.03M |
| March 31, 2015 | 129.93M |
| December 31, 2014 | 50.09M |
| September 30, 2014 | 53.41M |
| June 30, 2014 | 58.16M |
| March 31, 2014 | 63.96M |
| December 31, 2013 | 18.01M |
| September 30, 2013 | 18.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
248.16M
Minimum
Sep 2020
414.18M
Maximum
Mar 2023
314.82M
Average
264.24M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Verrica Pharmaceuticals Inc | 52.01M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 152.78M |
| Shareholders Equity (Quarterly) | 252.04M |